Pathstone Family Office’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.8M Buy
18,985
+9,806
+107% +$1.95M 0.03% 331
2023
Q2
$1.7M Sell
9,179
-191
-2% -$35.3K 0.02% 347
2023
Q1
$1.82M Sell
9,370
-5,004
-35% -$905K 0.03% 301
2022
Q4
$1.57M Buy
14,374
+2,686
+23% +$467K 0.03% 344
2022
Q3
$2.07M Buy
11,688
+2,396
+26% +$474K 0.04% 244
2022
Q2
$1.9M Buy
9,292
+1,126
+14% +$239K 0.04% 224
2022
Q1
$1.95M Sell
8,166
-885
-10% -$208K 0.05% 177
2021
Q4
$2.09M Buy
9,051
+3,224
+55% +$709K 0.05% 184
2021
Q3
$1.13M Sell
5,827
-720
-11% -$146K 0.03% 263
2021
Q2
$1.39M Buy
6,547
+2,534
+63% +$535K 0.04% 205
2021
Q1
$819K Buy
4,013
+3,659
+1,034% +$721K 0.03% 248
2020
Q4
$65K Buy
354
+223
+170% +$37.9K ﹤0.01% 470
2020
Q3
$22K Hold
131
– – ﹤0.01% 460
2020
Q2
$21K Hold
131
– – ﹤0.01% 417
2020
Q1
$22K Sell
131
-10
-7% -$1.99K ﹤0.01% 406
2019
Q4
$28.3K Buy
141
+12
+9% +$2.46K ﹤0.01% 366
2019
Q3
$27K Hold
129
– – ﹤0.01% 359
2019
Q2
$25K Sell
129
-77
-37% -$14.2K ﹤0.01% 417
2019
Q1
$34K Buy
206
+91
+79% +$16.1K ﹤0.01% 354
2018
Q4
$21K Buy
+115
New +$21.2K 0.01% 263
2017
Q2
– Sell
-14
Closed -$2K – 433
2017
Q1
$2K Buy
+14
New +$1.68K ﹤0.01% 375

Other funds holding CME

Pathstone Family Office's CME Position: Q3 2023 in Review

Pathstone Family Office increased its CME Group (CME) stake by 107% in Q3 2023, buying an estimated $1.95M and bringing the position to 18,985 shares worth $3.8M. The position accounts for 0.03% of the portfolio, ranked #331.

Pathstone Family Office first reported a position in CME in Q1 2017 and has held it in 21 quarters since. 1,230 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • Pathstone Family Office held 18,985 shares of CME Group worth $3.8M as of Q3 2023.
  • Pathstone Family Office bought 9,806 CME Group shares in Q3 2023, an estimated $1.95M.
  • CME Group made up 0.03% of Pathstone Family Office's portfolio in Q3 2023, its #331 holding.
  • Pathstone Family Office first reported a position in CME Group in Q1 2017 and has held it in 21 quarters since.
  • 1,230 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.